Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  ICo Therapeutics Inc.    ICO   CA45107J1057

ICO THERAPEUTICS INC.

(ICO)
  Report
Delayed Quote. Delayed TSX VENTURE EXCHANGE - 12/02 11:53:03 am
0.04 CAD   -11.11%
11/24ICO THERAPEUTICS : 3Q Earnings Snapshot
AQ
11/24ICO THERAPEUTICS : 3Q Earnings Snapshot
AQ
11/24iCo Therapeutics Announces Third Quarter 2020 Financial Results
NE
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
Quotes 5-day view   Delayed Quote. Delayed Tsx Venture Exchange
11/25/2020 11/26/2020 11/30/2020 12/01/2020 12/02/2020 Date
0.04(c) 0.045(c) 0.04(c) 0.045(c) 0.04 Last
7 000 562 958 55 000 82 000 4 000 Volume
0.00% +12.50% -11.11% +12.50% -11.11% Change
More quotes
Financials
Sales 2018 - - -
Net income 2018 -1,70 M -1,32 M -1,32 M
Net cash position 2018 0,01 M 0,01 M 0,01 M
P/E ratio 2018 -2,48x
Yield 2018 -
Sales 2019 - - -
Net income 2019 -1,94 M -1,50 M -1,50 M
Net cash position 2019 0,99 M 0,77 M 0,77 M
P/E ratio 2019 -5,05x
Yield 2019 -
Capitalization 6,92 M 5,35 M 5,35 M
EV / Sales 2018 -
EV / Sales 2019 -
Nbr of Employees 6
Free-Float 96,1%
More Financials
Company
iCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and develop drug candidates for the treatment of sight-and life-threatening diseases. The... 
More about the company
All news about ICO THERAPEUTICS INC.
11/24ICO THERAPEUTICS : 3Q Earnings Snapshot
AQ
11/24ICO THERAPEUTICS : 3Q Earnings Snapshot
AQ
11/24iCo Therapeutics Announces Third Quarter 2020 Financial Results
NE
10/26iCo Therapeutics Announces Option Grants
NE
10/21iCo Therapeutics Inc. Announces That Oral Amphotericin B (iCo-019) Results Wi..
NE
08/31ICO THERAPEUTICS : 2Q Earnings Snapshot
AQ
08/31iCo Therapeutics Announces Second Quarter 2020 Financial Results
NE
07/30iCo Therapeutics Inc. Announces Publication of Oral Amphotericin B (iCo 019) ..
NE
07/13iCo Therapeutics Announces First Quarter 2020 Financial Results
NE
06/22iCo Therapeutics Inc. Announces Oral Amphotericin B (iCo-019) Results to be P..
NE
05/29iCo Therapeutics Inc. Announces Q1 Interim Filing Update
NE
05/19iCo Therapeutics Announces 2019 Year End Financial Results
NE
04/27iCo Therapeutics Inc. Announces Annual Filing Update
NE
04/15iCo Therapeutics Inc. Announces Oral Amphotericin B (iCo 019) Update / Appoin..
NE
03/09iCo Therapeutics Announces Leadership Changes
NE
More news
News in other languages on ICO THERAPEUTICS INC.

- No features available -

More news
Chart ICO THERAPEUTICS INC.
Duration : Period :
iCo Therapeutics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 0,05 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
Managers
NameTitle
Bill W. Jarosz Chairman & Chief Executive Officer
Susan L. Koppy President & Director
Eugene Williams Chief Operating Officer
Michael Liggett Chief Financial Officer, Secretary & Director
Peter Hnik Chief Medical Officer & Director
Sector and Competitors
1st jan.Capitalization (M$)
ICO THERAPEUTICS INC.-43.75%5
MODERNA, INC.620.91%55 799
LONZA GROUP AG56.57%45 596
CELLTRION, INC.91.71%41 539
IQVIA HOLDINGS INC.10.82%32 829
SEAGEN INC.55.27%31 988